搜尋
LakeShore Biopharma Co Ltd
LSB添加自選
0.627USD
0.0000.00%
收盤 07/02, 13:00（美東）報價延遲15分鐘
13.02M總市值
--本益比TTM
關於 LakeShore Biopharma Co Ltd 公司
LakeShore Biopharma Co Ltd（原名 YS Biopharma Co Ltd）是一家生物製藥公司，致力於發現、開發、生產和商業化新一代傳染病和癌症疫苗和治療性生物製劑。公司的疫苗產品 YSJATM 狂犬病疫苗已實現商業化。公司還有四種處於不同臨牀開發階段的候選產品，包括 PIKA 狂犬病疫苗、PIKA 重組 COVID-19 疫苗、PIKA YS-ON-001 和 PIKA YS-HBV-001，以及四種臨牀前階段的候選產品，針對具有巨大醫療需求的 HBV、流感和癌症。此外，公司正在研究一系列處於發現階段的治療靶點、狂犬病和產品。
LakeShore Biopharma Co Ltd簡介
公司代碼LSB
公司名稱LakeShore Biopharma Co Ltd
上市日期Jul 30, 2021
CEOMr. Dave Chenn
員工數量573
證券類型Ordinary Share
年結日Jul 30
公司地址Building No. 2, 38 Yongda Road
城市BEIJING
上市交易所NASDAQ Capital Market Consolidated
國家China
郵編102629
電話
網址https://www.ysbiopharm.com/
公司代碼LSB
上市日期Jul 30, 2021
CEOMr. Dave Chenn
LakeShore Biopharma Co Ltd公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Mr. Gang Li
Mr. Gang Li
Head of Marketing and sales
Head of Marketing and sales
--
--
Dr. Stanley Yi Chang
Dr. Stanley Yi Chang
Independent Director
Independent Director
--
--
Dr. Ajit Shetty
Dr. Ajit Shetty
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Thomas Xue
Mr. Thomas Xue
Director
Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Yi Zhang
Mr. Yi Zhang
Chairman of the Board
Chairman of the Board
4.91M
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
462.76K
--
Dr. Hui (David) Shao
Dr. Hui (David) Shao
President, Co-Chief Executive Officer, Director, Chief Business Officer
President, Co-Chief Executive Officer, Director, Chief Business Officer
313.64K
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Zenaida Reynoso Mojares
Dr. Zenaida Reynoso Mojares
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
常見問題
LakeShore Biopharma Co Ltd的前五大股東是誰？
LakeShore Biopharma Co Ltd的前五大股東如下：Mr. Yi Zhang
有多少機構持有LakeShore Biopharma Co Ltd(LSB)的股份？
截至2026Q1，共有18家機構持有LakeShore Biopharma Co Ltd的股份，合計持有的股份價值約為606.46K，占公司總股份的1.47% 。與2025Q4相比，機構持股有所增加，增幅為-1434782.00。